Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams
1
x
$
30.00
Unmet Needs in the Treatment of Anxiety Disorders
1
x
$
30.00
Studying Non-Human Primates: A Gateway to Understanding Anxiety Disorders
1
x
$
30.00
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
1
x
$
30.00
Patricia K. Corey-Lisle, PhD, RN,CS-P: Economic Impact of Olanzapine Plus Fluoxetine Combination Therapy Among Patients Treated for Depression: A Pilot Study
1
x
$
30.00
Artículo original: Recuperación funcional en el primer episodio psicótico
1
x
$
0.00
Jun-Sheng Wang, MD, PhD: Pharmacokinetics and Drug Interactions of the Sedative Hypnotics
1
x
$
30.00
Treatment of Parental Depression and Reduced Risk in Offspring-Does It Have Anything to Do with Offspring Gender?
1
x
$
30.00
First Episode Psychosis in a Teen with Narcolepsy and Cataplexy
1
x
$
30.00
Effects of Discontinuation of Paliperidone Long-Acting Injectable After Switching from Risperidone Long-Acting Injectable Switching
1
x
$
30.00
Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia)
1
x
$
30.00
Surveying the Field of Gynecologic Oncology
1
x
$
0.00
Douglas G. Kondo, MD: An Evidence-Based Medicine Approach to Combined Treatment for ADHD in Children and Adolescents
1
x
$
30.00
Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome
1
x
$
30.00
Efficacy and Tolerability of Controlled-Release Paroxetine
1
x
$
30.00
View Cart
Checkout
Home
Store
“Efficacy and Tolerability of Controlled-Release Paroxetine” has been added to your cart.
View cart
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Patient Health Questionnaire
$
0.00
Add to cart
Details
Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj
$
30.00
Add to cart
Details
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
$
30.00
Add to cart
Details
Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study
$
30.00
Add to cart
Details
Paroxetine Use in Medically Ill Patients
$
30.00
Add to cart
Details
Paroxetine Treatment of Mood Disorders in Women: Premenstrual Dysphoric Disorder and Hot Flashes
$
30.00
Add to cart
Details
Paroxetine Treatment of Mood and Anxiety Disorders in Children and Adolescents
$
30.00
Add to cart
Details
Paroxetine Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Paroxetine Treatment of Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Paroxetine Treatment of Depression in Late Life
$
30.00
Add to cart
Details
Paolo Castrogiovanni, MD: Can Serotonin and Fluoxetine Levels in Plasma and Platelets Predict Clinical Response in Depression?
$
30.00
Add to cart
Details
Panic Disorder During Pregnancy
$
0.00
Add to cart
Details
Panel Discussion
$
30.00
Add to cart
Details
Palliative Chemotherapy for Advanced Colorectal Cancer
$
0.00
Add to cart
Details
Palliative Care Options for Advanced Prostate Cancer
$
0.00
Add to cart
Details
Paliperidone Palmitate Treatment in Outpatient Care Setting: A Naturalistic Study
$
30.00
Add to cart
Details
Paliperidone Induced Hypothyroidism: A Case Report
$
30.00
Add to cart
Details
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
$
30.00
Add to cart
Details
P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial
$
30.00
Add to cart
Details
P. Murali Doraiswamy, MD: Atypical Antipsychotics and Pituitary Neoplasms in the WHO Database
$
30.00
Add to cart
Details
Previous
1
…
16
17
18
…
44
Next
Page load link
Go to Top
